3,3-dimethyl-4-oxopentanoic acid | 23461-67-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: 3,3-dimethyl-4-oxopentanoic acid
• 英文别名: 3,3-Dimethyllevulinsaeure
• CAS: 23461-67-8
• 化学式: C₇H₁₂O₃
• mdl: MFCD00029814
• 分子量: 144.17
• InChiKey: VPFSRPKZLWVLPX-UHFFFAOYSA-N

物化性质

• 沸点：
  109-111 °C
• 密度：
  1.090 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918300090

SDS

Version 1.0
Regulation (EC) No 1907/2006

---

1 - Product and Company Information

---

Product Name 3,3-DIMETHYL-4-OXOVALERIC ACID - 50 MG

---

2 - Hazards Identification

---

SPECIAL INDICATION OF HAZARDS TO HUMANS AND THE ENVIRONMENT
Irritating to eyes, respiratory system and skin.

---

3 - Composition/Information on Ingredients

---

Product Name CAS # EC no Annex I
Index Number
3,3-DIMETHYL-4-OXOVALERIC ACID 23461-67-8 None None
Formula C7H12O3
Molecular Weight 144,1700 AMU

---

4 - First Aid Measures

---

AFTER INHALATION
If inhaled, remove to fresh air. If not breathing give
artificial respiration. If breathing is difficult, give oxygen.
AFTER SKIN CONTACT
In case of contact, immediately wash skin with soap and copious
amounts of water.
AFTER EYE CONTACT
In case of contact, immediately flush eyes with copious amounts
of water for at least 15 minutes.
AFTER INGESTION
If swallowed, wash out mouth with water provided person is
conscious. Call a physician.

---

5 - Fire Fighting Measures

---

EXTINGUISHING MEDIA
Suitable: Water spray. Carbon dioxide, dry chemical powder, or
ALDRICH www.molbase.com
appropriate foam.
SPECIAL RISKS
Specific Hazard(s): Emits toxic fumes under fire conditions.
SPECIAL PROTECTIVE EQUIPMENT FOR FIREFIGHTERS
Wear self-contained breathing apparatus and protective clothing
to prevent contact with skin and eyes.

---

6 - Accidental Release Measures

---

PROCEDURE(S) OF PERSONAL PRECAUTION(S)
Wear respirator, chemical safety goggles, rubber boots, and
heavy rubber gloves.
METHODS FOR CLEANING UP
Absorb on sand or vermiculite and place in closed containers for
disposal. Ventilate area and wash spill site after material
pickup is complete.

---

7 - Handling and Storage

---

HANDLING
Directions for Safe Handling: Do not breathe vapor. Avoid
contact with eyes, skin, and clothing. Avoid prolonged or
repeated exposure.

---

8 - Exposure Controls / Personal Protection

---

ENGINEERING CONTROLS
Mechanical exhaust required. Safety shower and eye bath.
GENERAL HYGIENE MEASURES
Wash thoroughly after handling.
PERSONAL PROTECTIVE EQUIPMENT
Respiratory Protection: Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US)
or CEN (EU). Where risk assessment shows air-purifying respirators
are appropriate use a full-face respirator with multi-purpose
combination (US) or type ABEK (EN 14387) respirator cartridges as
a backup to engineering controls. If the respirator is the sole
means of protection, use a full-face supplied air respirator.
Hand Protection: Compatible chemical-resistant gloves.
Eye Protection: Chemical safety goggles.

---

9 - Physical and Chemical Properties

---

pH N/A
BP/BP Range N/A
MP/MP Range N/A
Flash Point N/A
Flammability N/A
Autoignition Temp N/A
Oxidizing Properties N/A
Explosive Properties N/A
Explosion Limits N/A
Vapor Pressure N/A
Partition Coefficient Log Kow: 0,067
Viscosity N/A
ALDRICH www.molbase.com
Vapor Density N/A
Saturated Vapor Conc. N/A
Evaporation Rate N/A
Bulk Density N/A
Decomposition Temp. N/A
Solvent Content N/A
Water Content N/A
Surface Tension N/A
Conductivity N/A
Miscellaneous Data N/A
Solubility N/A

---

10 - Stability and Reactivity

---

STABILITY
Stable: Stable.
Materials to Avoid: Strong oxidizing agents.
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous Decomposition Products: Carbon monoxide, Carbon dioxide.
HAZARDOUS POLYMERIZATION
Hazardous Polymerization: Will not occur

---

11 - Toxicological Information

---

SIGNS AND SYMPTOMS OF EXPOSURE
To the best of our knowledge, the chemical, physical, and
toxicological properties have not been thoroughly investigated.
ROUTE OF EXPOSURE
Skin Contact: Causes skin irritation.
Skin Absorption: May be harmful if absorbed through the skin.
Eye Contact: Causes eye irritation.
Inhalation: Material is irritating to mucous membranes and upper
respiratory tract. May be harmful if inhaled.
Ingestion: May be harmful if swallowed.

---

12 - Ecological Information

---

No data available.

---

13 - Disposal Considerations

---

SUBSTANCE DISPOSAL
Contact a licensed professional waste disposal service to dispose
of this material. Dissolve or mix the material with a combustible
solvent and burn in a chemical incinerator equipped with an
afterburner and scrubber. Observe all federal, state, and local
environmental regulations.

---

14 - Transport Information

---

RID/ADR
Non-hazardous for road transport.
IMDG
Non-hazardous for sea transport.
IATA
ALDRICH www.molbase.com
Non-hazardous for air transport.

---

15 - Regulatory Information

---

CLASSIFICATION AND LABELING ACCORDING TO EU DIRECTIVES
INDICATION OF DANGER: Xi
Irritant.
R-PHRASES: 36/37/38
Irritating to eyes, respiratory system and skin.
S-PHRASES: 26-36/37
In case of contact with eyes, rinse immediately with plenty of
water and seek medical advice. Wear suitable protective
clothing and gloves.
Caution: Substance not yet fully tested (EU).

---

16 - Other Information

---

WARRANTY
The above information is believed to be correct but does not
purport to be all inclusive and shall be used only as a guide. The
information in this document is based on the present state of our
knowledge and is applicable to the product with regard to
appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Inc.,
shall not be held liable for any damage resulting from handling or
from contact with the above product. See reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2010 Co. License granted to make
unlimitedpaper copies for internal use only.
DISCLAIMER
For R&D use only. Not for drug, household or other uses.
ALDRICH www.molbase.com

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3,3-dimethyl-4-oxopentanoic acid 在 sodium hydroxide 、 potassium permanganate 、 sodium 作用下， 生成 3,3-dimethyl-2-oxo-glutaric acid
  参考文献：
  名称：

  Antibiotic

  摘要：

  该化合物由以下结构式表示：##STR1## 其中，R1代表氨基或通过氮原子连接的有机残基；R2代表羧基或由此衍生的基团；R3、R4、R5、R6、R7和R8各自独立地代表氢或有机残基，包括R5或R6与R7或R8形成化学键或环的情况；X代表氢、甲氧基或甲酰氨基；或其盐，可通过本方法制备，表现出优异的抗菌活性，并被用作抗菌剂。

  公开号：

  US04851422A1
• 作为产物：
  描述：

  1,2,3,3-四甲基环戊烯 在 potassium permanganate 作用下， 生成 3,3-dimethyl-4-oxopentanoic acid
  参考文献：
  名称：

  Tiemann, Chemische Berichte, 1897, vol. 30, p. 597

  摘要：

  DOI：

文献信息

• C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20130296554A1

  公开（公告）日：2013-11-07

  Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, C-17 bicyclic amines of triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III: These compounds are useful for the treatment of HIV and AIDS.

  具有药物和生物活性的化合物、其药物组合物及其使用方法在此予以说明。特别是，提供了具有独特抗病毒活性的C-17双环胺三萜类化合物，作为HIV成熟抑制剂，由公式I、II和III所示的化合物代表：这些化合物可用于治疗HIV和艾滋病。
• [EN] CARBONYL DERIVATIVES OF BETULIN<br/>[FR] DÉRIVÉS CARBONYLES DE BÉTULINE
  申请人：GLAXOSMITHKLINE LLC

  公开号：WO2013020245A1

  公开（公告）日：2013-02-14

  Disclosed are a compound characterized by the following formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising said compound or a pharmaceutically acceptable salt thereof, wherein R3, L, and A are as described in the application. Said compounds are useful for the treatment of HIV.

  揭示了一种由以下化学式I或其药学上可接受的盐所表征的化合物，以及包含所述化合物或其药学上可接受的盐的药物组合物，其中R3、L和A如申请中所述。所述化合物对治疗HIV有用。
• [EN] GRANZYME B INHIBITOR FORMULATIONS AND METHODS FOR THE TREATMENT OF BURNS<br/>[FR] FORMULATIONS INHIBITRICES DE GRANZYME B ET MÉTHODES DE TRAITEMENT DE BRÛLURES
  申请人：VIDA THERAPEUTICS INC

  公开号：WO2017132771A1

  公开（公告）日：2017-08-10

  Formulations for treating burns and burn wound healing comprising a Granzyme B inhibitor and a pharmaceutically acceptable carrier, and methods for treating burns and for burn wound healing using the formulations.

  治疗烧伤和烧伤愈合的配方包括一种Granzyme B抑制剂和一种药用可接受载体，以及使用这些配方进行治疗烧伤和烧伤愈合的方法。
• BETULINIC ACID DERIVATIVES AS ANTI-HIV AGENTS
  申请人：Chen Chin Ho

  公开号：US20110152229A1

  公开（公告）日：2011-06-23

  The present invention provides compounds of the general structure: which are substituted at the 3 and 28 positions, along with pharmaceutical formulations containing the same and methods of treating viral infections employing the same.

  本发明提供了一般结构的化合物，其在3和28位置被取代，以及含有这些化合物的药物配方，以及利用这些化合物治疗病毒感染的方法。
• [EN] LUPANE TRITERPENOID DERIVATIVES AND PHARMACEUTICAL USE THEREOF<br/>[FR] DÉRIVÉS DE TRITERPÉNOÏDES DE LUPANE ET LEUR UTILISATION PHARMACEUTIQUE
  申请人：JIANGXI QINGFENG PHARMACEUTICAL INC

  公开号：WO2013117137A1

  公开（公告）日：2013-08-15

  Disclosed are lupane triterpenoid derivatives and pharmaceutical use thereof, specifically lupane triterpenoid derivatives of formulae (I)~(III), a pharmaceutical composition and a combination preparation comprising said lupane triterpenoid derivatives or a pharmaceutically acceptable salt thereof in a therapeutically-effective dose, particularly the use in preparation of a medicament for the treatment of HIV-1/AIDS.

  本文披露了鲁班三萜衍生物及其药用，具体为公式(I)~(III)的鲁班三萜衍生物，以及包含所述鲁班三萜衍生物或其药用可接受盐的药物组合物和联合制剂，在治疗有效剂量中使用，特别是在制备治疗HIV-1/AIDS的药物中的应用。